The influence of ACE inhibitors and ARBs on hospital length of stay and survival in people with COVID-19.

P, Braude; B, Carter; R, Short; A, Vilches-Moraga; A, Verduri; L, Pearce; A, Price; TJ, Quinn; M, Stechman; J, Collins; E, Bruce; A, Einarsson; F, Rickard; E, Mitchell; M, Holloway; J, Hesford; F, Barlow-Pay; E, Clini; PK, Myint; S, Moug; K, McCarthy; J, Hewitt

doi:10.1016/j.ijcha.2020.100660

Public

The influence of ACE inhibitors and ARBs on hospital length of stay and survival in people with COVID-19.

Shared by NobleBlocks on Oct 15, 2020 • 12:00 AM UTC

Authors:

Braude P

Carter B

Short R

Abstract

Objective During the COVID-19 pandemic the continuation or cessation of angiotensin-converting enzyme inhibitors (ACEi) and angiotensin receptor blockers (ARBs) has been contentious. Mechanisms have been proposed for both beneficial and detrimental effects. Recent studies have focused on mortality w...

Subject

Angiotensin-converting enzyme inhibitors

Coronavirus

Hospitalization

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!